Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: May 26, 2022
Open Peer Review Period: May 26, 2022 - Jul 21, 2022
Date Accepted: Nov 14, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review

Crawford R, Sikirica S, Morrison R, Cappelleri JC, Russell-Smith A, Shah R, Chadwick H, Doward L

The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review

JMIR Cancer 2023;9:e39852

DOI: 10.2196/39852

PMID: 37126376

PMCID: 10186186

The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: A Social Media Review

  • Rebecca Crawford; 
  • Slaven Sikirica; 
  • Ross Morrison; 
  • Joseph C Cappelleri; 
  • Alexander Russell-Smith; 
  • Richa Shah; 
  • Helen Chadwick; 
  • Lynda Doward

ABSTRACT

Background:

Adult patients with acute lymphoblastic leukemia (ALL) report substantial disease- and treatment-related impacts on their health-related quality of life (HRQOL). Patient-reported information (PRI) shared on social media may provide a distinct opportunity to understand the patient experience outside of formal research contexts and help inform the development of novel therapies.

Objective:

To assess the PRI shared on social media websites to gain a better understanding of the symptom, HRQOL, and treatment impacts on individuals with ALL.

Methods:

This qualitative social media review identified English-language posts on three patient advocacy websites (Patient Power, The Patient Story, and Leukemia Care) and YouTube that included PRI about experiences with ALL and/or ALL treatments shared by adults (aged ≥18 years) with a self-reported ALL diagnosis. Patients’ demographic and disease characteristics were extracted from posts (where available), and posts were analyzed thematically. A network analysis was conducted to delineate possible associations among ALL symptoms, HRQOL impacts, and treatment-related symptoms and impacts.

Results:

Of the 935 social media posts identified, 63 met the review criteria: 40 videos, 5 comments posted in response to videos, and 18 blog posts. The 63 posts were contributed by 41 individual patients (21 males, 18 females, 2 not reported); 13 patients contributed >1 source of data. Fatigue (n=20, 49%), shortness of breath (n=13, 32%), and bruising (n=12, 29%) were the symptoms prior to treatment most frequently discussed by patients. Patients also reported impacts on personal relationships (n=26, 63%), psychological and emotional well-being (n=25, 61%), and work (n=16, 39%). Although inpatient treatment reportedly restricted patients’ independence and social functioning, it also provided a few patients with a sense of safety. Patients frequently relied on their doctors to drive their treatment decisions but were also influenced by family members. The network analysis indicated that disease-related symptoms were primarily associated with patients’ physical functioning, activities of daily living, and ability to work, while treatment-related symptoms were primarily associated with emotional well-being.

Conclusions:

Patients’ social media posts suggest that inpatient care for ALL is associated with restricted independence and social functioning. However, inpatient care also provided a sense of safety for some patients. This novel review of PRI indicates that treatment and ALL-related symptoms are associated with different HRQOL impacts, showing an explicit link between treatment-related symptoms and emotional well-being.


 Citation

Please cite as:

Crawford R, Sikirica S, Morrison R, Cappelleri JC, Russell-Smith A, Shah R, Chadwick H, Doward L

The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review

JMIR Cancer 2023;9:e39852

DOI: 10.2196/39852

PMID: 37126376

PMCID: 10186186

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.